Beximco Group - The Rising Solitaire in Bangladesh

Today, Beximco Group is the biggest corporate house in Bangladesh and is slowly conquering the international market. The clear aim of the group is to find new ways to enhance the private sector of Bangladesh and increase its vastness. In recent times, Beximco Group has built valuable relationships in countries like Canada and United States of America for exporting its medicines and textiles.

Formed in 1972, the Beximco Group came into being right after independence of Bangladesh, thus making it one of the oldest sustaining corporate setups in the country.

Over the time span of more than 40 years, the company has grown from strength to strength and established itself firmly as the top business group in Bangladesh. Mr. Salman F Rahman has played a major role in Beximco Group’s adding up to the economy of the nation and improving lives of the people. He has entrenched the corporate integrity of the group and is the brain behind many progressive policies of the company. 

Beximco Group has continuously been contributing to Bangladesh’s economy and its intention is to take the country to a new lane of achievements. The group is involved in many sectors such as pharmaceuticals, IT and broadcasting, media, real sstate, construction, textile and garments, and ceramic. 

Today, the organization provides employment to around sixty -five thousand people, and this all has been possible today due to the clear vision of brothers Sohail F Rahman and Salman F Rahman who aim to take Bangladesh to the world.

Beximco Pharma Is In the Forefront of Industry Developments

Beximco Pharmaceuticals Ltd. has reached another milestone as it won the much reputed Scrip Award recently. The Bangladeshi pharmaceuticals giant has been in the forefront of many progressive developments of the industry. In 2003, the company was the first to introduce anti-retroviral (AVR) drugs in Bangladesh. In 2009, it became the only Bangladeshi company to receive GMP approval from ANSIVA, Brazil. Beximco is also one of the very few and first pharmaceutical companies of Bangladesh to have received approval for export operations to the European and American markets. 

The recent Scrip Award in the category of ‘Best Company in an Emerging Market’ is an award that recognizes individuals and companies that have demonstrated excellent performance towards significant contribution in the healthcare industry. The founders of Beximco, Sohail F Rahman and Salman F Rahman, both prominent Bangladeshi businessmen are positive on the future of the pharmaceuticals industry of Bangladesh, especially on export operations.

Beximco recently signed a MoU with Nuvista pharma to acquire 85.22% shareholding of that company. The acquisition is expected to strengthen Beximco’s presence in the steroid and hormones segment. This is a big boost not only for the company but for the entire economy as a whole. Bangladesh is one of the fastest growing economies; ranked 2nd by the IMF. Export operations being major contributors to this robust growth, the pharmaceuticals industry remains a key contributor. As we know that South East Asia, let alone the other regions, has a huge market for pharmaceutical products, and developments in the industry will definitely serve as a major impetus for the growth of both the industry and the economy.